3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neuroblastoma
5
Medulloblastoma
5
Carcinoma
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Ganglioneuroblastoma
3
Vulvar Neoplasms
2
Stomach Neoplasms
2
Oropharyngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vomiting
1
Urinary Bladder Neoplasms
1
Teratoma
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Sertoli-Leydig Cell Tumor
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Papillomavirus Infections
1
Ovarian gynandroblastoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nausea
1
Lymphoid Interstitial Pneumonia
1
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
Platinum
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts